ロード中...
Long-term follow-up of complete remission of advanced hepatocellular carcinoma following sorafenib therapy: A case report
Sorafenib is a tyrosine kinase inhibitor that has been demonstrated to improve the overall survival time of patients with advanced hepatocellular carcinoma (HCC). Although there have been a number of reports of patients achieving complete remission (CR) following sorafenib therapy, the long-term cli...
保存先:
| 出版年: | Oncol Lett |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649582/ https://ncbi.nlm.nih.gov/pubmed/29085491 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6788 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|